Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/31/2021 40 44
Cepharanthine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021 6 0
Tetrandrine Potential treatment - pre-clinical evidence Natural product Antiviral Mar/23/2021 4 0
Cyclosporine Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/23/2021 7 0
Salinomycin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021 4 1
Remdesivir Approved by FDA Experimental Antiviral Mar/23/2021 60 4
Nafamostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/20/2021 12 0
Amodiaquine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/12/2021 6 0
Emetine Potential treatment - pre-clinical evidence Experimental Antiviral Mar/10/2021 7 0
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/08/2021 25 7